| Period | Net Revenue | Cost of Revenue | Net Profit | EPS |
|---|---|---|---|---|
| FY2023 | 544.56M |
334.19M | 544.56M |
$-2.63 |
| Q32023 |
123.26M
-7.5%
|
71.75M |
-21.3M
-67.8%
|
$-0.72 |
| Q22023 |
133.23M
-13.8%
|
84.82M |
-12.69M
-6.7%
|
$-0.42 |
| Q12023 |
154.54M
|
93.21M |
-11.9M |
$-0.55 |
| FY2022 | 551.13M |
328.52M | -22.01M |
$-1.14 |
| Q42022 |
193.81M
+48.3%
|
119.61M |
-5.04M
+46.9%
|
$-0.23 |
| Q32022 |
130.68M
+15.2%
|
76.26M |
-9.49M
-123.4%
|
$-0.44 |
| Q22022 |
113.44M
+0.2%
|
65.46M |
-4.25M
-31.6%
|
$-0.22 |
| Q12022 |
113.2M
|
67.2M |
-3.23M |
$-0.21 |
| FY2021 | 454.17M |
287.12M | -13.23M |
$-1.23 |
| FY2020 | 501.82M |
338.19M | -56.3M |
$-7.54 |
| FY2019 | 596.64M |
389.79M | -22.16M |
$-3.4 |
| Period | Total Assets | Total Liabilities | Cash & Eq. | Debt | Stock Equity |
|---|---|---|---|---|---|
| FY2023 | 443.75M |
426.71M | 7.19M |
191.81M |
17.04M |
| Q32023 | 462.04M |
425.42M | 9.07M |
199.2M |
36.63M |
| Q22023 | 482.82M |
427.77M | 19.9M |
199.14M |
55.05M |
| Q12023 | 508.06M |
454.41M | 12.05M |
206.28M |
51.56M |
| FY2022 | 522.65M |
453.28M | 11.3M |
214.33M |
66.95M |
| FY2021 | 226.64M |
199.59M | 15.49M |
57.86M |
27.05M |
| FY2020 | 212.74M |
194.05M | 10.29M |
73.44M |
18.69M |
| FY2019 | 229.99M |
165.04M | 20.49M |
73.91M |
64.95M |
| Period | Operating CF | Investing CF | Financing CF | Capex | Free Cash Flow | FY2023 | Not reported yet. |
|---|---|---|---|---|---|
| Q32023 | 0 |
0 | 0 |
0 |
0
+100%
|
| Q22023 | -2.89M |
-3.05M | 13.28M |
-3.05M |
-5.94M
+32.6%
|
| Q12023 | -6.7M |
-2.13M | 9.58M |
-2.13M |
-8.82M
|
| FY2022 | -49.98M |
-116.45M | 162.61M |
-10.04M |
-60.01M |
| FY2021 | 6.23M |
-4.89M | 3.86M |
-4.89M |
1.34M |
| FY2020 | -6.16M |
-7.78M | 3.29M |
-7.15M |
-13.3M |
| FY2019 | 7.21M |
-8.1M | -2.56M |
-8.77M |
-1.56M |
Kewaunee Scientific Co...
Charles & Colvard, Ltd...
EBET, Inc.
LMP Automotive Holding...
Brilliant Earth Group,...
Ayro, Inc.
MEDIROM Healthcare Tec...